All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

331

Reset

331 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • certepetideCEND-1, LSTA1Phase 21 trial

    Lisata Therapeutics, Inc. · Cholangiocarcinoma, Gallbladder Cancer, Gallbladder Carcinoma

  • CM338Phase 21 trial

    Keymed Biosciences Co.Ltd · IgA Nephropathy

  • CP-383Phase 21 trial

    Tasca Therapeutics · Solid Tumor Malignancies, Colorectal Carcinoma, Small Cell Lung Cancer ( SCLC )

  • CRG-150Phase 21 trial

    CoRegen, Inc. · HR-positive, HER2-negative Breast Cancer, TNBC - Triple-Negative Breast Cancer, Prostate Cancer

  • CU01-1001Phase 21 trial

    Curacle Co., Ltd. · Diabetic Nephropathies

  • Debio 4228Phase 21 trial

    Debiopharm International SA · Prostate Cancer

  • DM002Phase 21 trial

    Xadcera Biopharmaceutical (Suzhou) Co., Ltd. · Ovarian Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

  • EB-701CA9-NKPhase 21 trial

    Beijing Biotech · Advanced or Metastatic Clear Cell Renal Cell Carcinoma

  • EG-70Phase 21 trial

    enGene, Inc. · Superficial Bladder Cancer, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ, Non-muscle Invasive Bladder Cancer

  • ETX-19477Phase 21 trial

    858 Therapeutics, Inc. · Advanced or Metastatic Solid Tumors, Breast Cancer, Ovarian Cancer

  • EVER001Phase 21 trial

    Everest Medicines (China) Co.,Ltd. · Minimal Change Disease (MCD), IgA Nephropathy (IgAN), Focal Segmental Glomerulosclerosis (FSGS)

  • FG-3246FOR46Phase 21 trial

    Kyntra Bio · Metastatic Castration-Resistant Prostate Cancer

  • FOG-001Phase 21 trial

    Parabilis Medicines, Inc. · Cancer, Colorectal Cancer, Solid Tumor

  • FT819Phase 21 trial

    Fate Therapeutics · Lupus Nephritis, Systemic Lupus Erythematosus, SLE - Systemic Lupus Erythematosus

  • Ga-68-NGULPhase 21 trial

    Cellbion Co., Ltd. · Prostate Cancer, mCRPC

  • GDC-1261Phase 21 trial

    Roche (Genentech) · Advanced Prostate Cancer, Metastatic Prostate Cancer

  • GI-101Phase 21 trial

    GI Innovation, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Cervical Cancer

  • GI-101APhase 21 trial

    GI Innovation, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Cervical Cancer

  • GI-108Phase 21 trial

    GI Innovation, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Non-small Cell Lung Cancer (NSCLC)

  • GM103Phase 21 trial

    GeneMedicine Co., Ltd. · Head and Neck Cancer, Malignant Melanoma, Colorectal Cancer

  • GSK5458514Phase 21 trial

    GSK · Neoplasms, Prostate

  • GSK5471713Phase 21 trial

    GSK · Neoplasms, Prostate

  • GVV858Phase 21 trial

    Novartis · Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Metastatic Castration-resistant Prostate Cancer

  • HLX01Phase 21 trial

    Shanghai Henlius Biotech · Membranous Nephropathy, Lupus Nephritis (LN)

  • HLX79Phase 21 trial

    Shanghai Henlius Biotech · Membranous Nephropathy, Lupus Nephritis (LN)

  • HP518Phase 21 trial

    Hinova Pharmaceuticals Inc. · Metastatic Castration-resistant Prostate Cancer

  • HRS-1738Phase 21 trial

    Jiangsu HengRui Medicine Co., Ltd. · PET Imaging in Patients With Prostate Cancer

  • HS-10390Phase 21 trial

    Jiangsu Hansoh Pharmaceutical Co., Ltd. · Chronic Kidney Disease

  • HS-10516Phase 21 trial

    Jiangsu Hansoh Pharmaceutical Co., Ltd. · Advanced Clear Cell Renal Cell Carcinoma

  • HS-10566Phase 21 trial

    Jiangsu Hansoh Pharmaceutical Co., Ltd. · High-risk Non-muscle-invasive Bladder Cancer

  • IAM1363Phase 21 trial

    Iambic Therapeutics, Inc · HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer

  • IBR854Phase 21 trial

    Imbioray (Hangzhou) Biomedicine Co., Ltd. · Renal Cell Carcinoma (RCC)

  • IG3018Phase 21 trial

    Intelligem Therapeutics Australia Pty Ltd. · Hyperuricemia, Hypouricemia, Renal

  • IGT-303Phase 21 trial

    Ingenia Therapeutics INC · Healthy Volunteers, Chronic Kidney Disease

  • INV-9956Phase 21 trial

    Shenzhen Ionova Life Sciences Co., Ltd. · Advanced Metastatic Castration Resistant Prostate Cancer

  • JMT601Phase 21 trial

    Shanghai JMT-Bio Inc. · Primary Membranous Nephropathy

  • KELI-101Phase 21 trial

    Kelifarma · Preemptive Therapy of Patients At Risk for Acute Kidney Injury Following Cardiac Surgery

  • KJ103Phase 21 trial

    Shanghai Bao Pharmaceuticals Co., Ltd. · Anti-Glomerular Basement Membrane Disease

  • KP104Phase 21 trial

    Kira Pharmacenticals (US), LLC. · Glomerulonephritis

  • KVA12123Phase 21 trial

    Kineta Inc. · Cancer, Solid Tumor, Melanoma

  • LLX-424Phase 21 trial

    Lilac Therapeutics, Inc. · Kidney Stones

  • LSALT PeptideMetablokPhase 21 trial

    Arch Biopartners Inc. · Acute Kidney Injury, Cardiac Surgery

  • Lu-177-DGULPhase 21 trial

    Cellbion Co., Ltd. · Prostate Cancer, mCRPC

  • MHB048CPhase 21 trial

    Minghui Pharmaceutical (Hangzhou) Ltd · mCRPC (Metastatic Castration-resistant Prostate Cancer), Advanced Malignant Solid Tumor

  • MIL116Phase 21 trial

    Beijing Mabworks Biotech Co., Ltd. · Immunoglobulin A Nephropathy

  • MZE829Phase 21 trial

    Maze Therapeutics · Proteinuric Kidney Disease

  • NBIP-01435Phase 21 trial

    Neurocrine Biosciences · Congenital Adrenal Hyperplasia

  • NDI-101150Phase 21 trial

    Nimbus Saturn, Inc. · Solid Tumor, Renal Cell Carcinoma (Kidney Cancer), Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma

  • NUV-1511Phase 21 trial

    Nuvation Bio Inc. · Advanced Solid Tumor, HER2-negative Breast Cancer, Metastatic Castration-resistant Prostate Cancer (mCRPC)

  • TransThera Sciences (Nanjing), Inc. · Prostate Cancer (CRPC)

NewerPage 6 of 7Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.